Study Summary
This trial will test whether a mobile app can help transplant survivors with sexual health problems.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 8 Secondary · Reporting Duration: 2 years
2 years
To assess the feasibility of the intervention
8 and 12 weeks
Compare patient reported anxiety symptoms (HADS-anxiety) between the two study groups
Compare patient reported depression symptoms (HADS-depression) between the two study groups
Compare patient reported quality of life (FACT-BMT) between the study groups
Compare patient-reported global satisfaction with sex (PROMIS Sexual Function and Satisfaction Measure) between the study groups
Compare patient-reported interest in sexual activity (PROMIS Sexual Function and Satisfaction Measure - Interest in sexual activity domain) between the study groups
Compare patient-reported orgasm (PROMIS Sexual Function and Satisfaction Measure - Orgasm domain) between the study groups
For females: compare patient-reported lubrication and vaginal comfort (PROMIS Sexual Function and Satisfaction Measure - lubrication and vaginal comfort domains) between the study groups
For males: compare patient-reported erectile function (PROMIS Sexual Function and Satisfaction Measure - Erectile function domain) between the study groups
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Mobile app plus enhanced standard care
1 of 1
Experimental Treatment
60 Total Participants · 1 Treatment Group
Primary Treatment: Mobile App + enhanced standard care · No Placebo Group · N/A
Mobile app plus enhanced standard careExperimental Group · 2 Interventions: Mobile App + enhanced standard care, Enhanced Standard Care · Intervention Types: Behavioral, Other
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 2 years
Who is running the clinical trial?
Massachusetts General HospitalLead Sponsor
2,700 Previous Clinical Trials
30,853,072 Total Patients Enrolled
4 Trials studying Other Cancers
30,291 Patients Enrolled for Other Cancers
Areej El-Jawahri, MDPrincipal InvestigatorMassachusetts General Hospital
16 Previous Clinical Trials
4,555 Total Patients Enrolled
Eligibility Criteria
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:You are able to communicate in English or able to complete questionnaires with assistance required from an interpreter or family member.
You have a positive screen for sexual dysfunction that is causing distress based on the NCCN survivorship guidelines.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments